Company

Cerberus Therapeutics

Biotechnology Research Cambridge, Massachusetts, United States 8 employees

Employees: 8
Contacts: 3
Emails: 3

www.cerberustx.com LinkedIn

Cerberus Therapeutics Overview

Headquarters: Cambridge, Massachusetts, United States
Website: www.cerberustx.com
Industry: Biotechnology Research
Employees: 8
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

About Cerberus Therapeutics

Cerberus Therapeutics utilizes nanobody-based platform to create novel therapeutics for modulating the immune system. The COVID-19 pandemic highlights the need for safe and accessible therapies to modulate our immune responses. We have developed strategies that allows for precise turning on/off the immune system in response to debilitating diseases. Our pilot programs focus on autoimmune disorders and infectious diseases, that are based on novel biological discoveries originating from decades of work by our three founders: Dr. Novalia Pishesha, Prof. Hidde Ploegh, and Prof. Harvey Lodish.

Cerberus Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage

Cerberus Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Helen Rich	Scientist at Cerberus Therapeutics	Somerville, Massachusetts, United States	Email
Rhogerry Deshycka	Founding Team at Cerberus Therapeutics	San Francisco, California, United States	Email
Laura Pietrok	Immunologist	Cambridge, Massachusetts, United States	View
Novalia Pishesha	Boston Children's Hospital	Cambridge, Massachusetts, United States	Email